DPP4i vs placebo
Pancreatitis · CVD (ASCVD, HF, or both)
DPP4i probably leads to higher pancreatitis compared with placebo (moderate certainty).
1 finding from 1 review
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes onlyOR 1.63 [1.12, 2.37]5 studies · 47684 participantsModerate